Is MGM-15 (dihydro-7-hydroxymitragynine) Legal in Kansas? (2026)

Instrument

Controlled substance analog definition; Schedule I opiates including 7-hydroxymitragynine

Source

https://www.kslegislature.gov/b2025_26/bills/download/?apn=b2025_26/year2/ready_for_publication/hb_2365/hb2365_enrolled.pdf

Retrieved

2026-10-29

Fingerprint

bad4fd4b670d8f1f

K.S.A. 2025 Supp. 21-5701 is hereby amended to read
as follows: 21-5701. As used in K.S.A. 21-5701 through 21-5717, and
amendments thereto:

(a) “Controlled   substance”   means   any   drug,   substance   or
immediate   precursor   included   in  any of  the   schedules  designated  in
K.S.A.   65-4105,   65-4107,   65-4109,   65-4111   and   65-4113,   and
amendments thereto.

(b) (1) “Controlled substance analog” means  a substance that is

intended for human consumption, and at least one of the following:

(A) The chemical structure of the substance is substantially similar
to the chemical structure of a controlled substance listed in or added to
the   schedules   designated   in   K.S.A.   65-4105   or   65-4107,   and
amendments thereto;

(B) the   substance   has   a   stimulant,   depressant   or   hallucinogenic
effect   on   the   central   nervous   system   substantially   similar   to   the
stimulant, depressant  or hallucinogenic effect on the central  nervous
system of a controlled substance included in the schedules designated
in K.S.A. 65-4105 or 65-4107, and amendments thereto; or

(C) with   respect   to   a   particular   individual,   such   individual
represents or intends the substance to have a stimulant, depressant or
hallucinogenic   effect   on   the   central   nervous   system   substantially
similar   to   the   stimulant,   depressant   or   hallucinogenic   effect   on   the
central   nervous   system   of   a   controlled   substance   included   in   the
schedules designated in K.S.A. 65-4105 or 65-4107, and amendments
thereto.

(2) “Controlled substance analog” does not include:
(A) A controlled substance;
(B) a   substance   for   which   there   is   an   approved   new   drug

application; or

(C) a substance with respect to which an exemption is in effect for
investigational   use   by   a   particular   person   under   section   505   of   the
federal food, drug, and cosmetic act, 21 U.S.C. § 355, to the extent
conduct with respect to the substance is permitted by the exemption.

K.S.A. 2025 Supp. 65-4105 is hereby amended to read as
follows: 65-4105. (a) The controlled substances listed in this section are
included in schedule I and the number set forth opposite each drug or
substance is the DEA controlled substances code that has been assigned
to it.

(b) Any of the following opiates, including their isomers, esters,
ethers, salts, and salts of isomers, esters and ethers, unless specifically
excepted, whenever the existence of these isomers, esters, ethers and
salts is possible within the specific chemical designation:

Instrument

Controlled substance analog; Schedule I opiates (7-hydroxymitragynine, mitragynine); unlawful distribution

Source

https://www.kslegislature.gov/b2025_26/bills/download/?apn=b2025_26/year2/ready_for_publication/hb_2365/hb2365_enrolled.pdf

Retrieved

2026-11-08

Fingerprint

cdeccc00200c8db0

(b) (1) “Controlled substance analog” means a substance that is
intended for human consumption, and at least one of the following:
(A) The chemical structure of the substance is substantially similar
to the chemical structure of a controlled substance listed in or added to
the schedules designated in K.S.A. 65-4105 or 65-4107, and
amendments thereto;
(B) the substance has a stimulant, depressant or hallucinogenic
effect on the central nervous system substantially similar to the
stimulant, depressant or hallucinogenic effect on the central nervous
system of a controlled substance included in the schedules designated
in K.S.A. 65-4105 or 65-4107, and amendments thereto; or
(C) with respect to a particular individual, such individual
represents or intends the substance to have a stimulant, depressant or
hallucinogenic effect on the central nervous system substantially
similar to the stimulant, depressant or hallucinogenic effect on the
central nervous system of a controlled substance included in the
schedules designated in K.S.A. 65-4105 or 65-4107, and amendments
thereto.
(2) “Controlled substance analog” does not include:
(A) A controlled substance;
(B) a substance for which there is an approved new drug
application; or
(C) a substance with respect to which an exemption is in effect for
investigational use by a particular person under section 505 of the
federal food, drug, and cosmetic act, 21 U.S.C. § 355, to the extent
conduct with respect to the substance is permitted by the exemption.

(a) The controlled substances listed in this section are included in
schedule I and the number set forth opposite each drug or substance is
the DEA controlled substances code that has been assigned to it.
(b) Any of the following opiates, including their isomers, esters,
ethers, salts, and salts of isomers, esters and ethers, unless specifically
excepted, whenever the existence of these isomers, esters, ethers and
salts is possible within the specific chemical designation:

(32) 7-hydroxymitragynine (7-OH)

(42) Mitragynine

(a) It shall be unlawful for any person to distribute or possess with the intent to distribute any of the following controlled substances or controlled substance analogs thereof:
(1) Opiates, opium or narcotic drugs, or any stimulant designated in K.S.A. 65-4107(d)(1), (d)(3) or (f)(1), and amendments thereto;
(2) any depressant designated in K.S.A. 65-4105(e), 65-4107(e), 65-4109(b) or (c) or 65-4111(b), and amendments thereto;
(3) any stimulant designated in K.S.A. 65-4105(f), 65-4107(d)(2), (d)(4), (d)(5) or (f)(2) or 65-4109(e), and amendments thereto;
(4) any hallucinogenic drug designated in K.S.A. 65-4105(d), 65-4107(g) or 65-4109(g), and amendments thereto;
(5) any substance designated in K.S.A. 65-4105(g) or 65-4111(c), (d), (e), (f) or (g), and amendments thereto;
(6) any anabolic steroids as defined in K.S.A. 65-4109(f), and amendments thereto; or
(7) any substance designated in K.S.A. 65-4105(h), and amendments thereto.

Instrument

Schedule I: opiates (7-hydroxymitragynine; mitragynine)

Source

https://www.kslegislature.gov/b2025_26/bills/download/?apn=b2025_26/year2/ready_for_publication/sb_430/sb430_enrolled.pdf

Retrieved

2026-10-29

Fingerprint

d9222d89912ff79a

K.S.A. 2025 Supp. 65-4105, as amended by section 2 of
2025 House Bill No. 2365, is hereby amended to read as follows: 65-
4105. (a) The controlled substances listed in this section are included in
schedule I and the number set forth opposite each drug or substance is
the DEA controlled substances code that has been assigned to it.

(b) Any of the following opiates, including their isomers, esters,
ethers, salts, and salts of isomers, esters and ethers, unless specifically
excepted, whenever the existence of these isomers, esters, ethers and
salts is possible within the specific chemical designation:

Instrument

Kansas Schedule I opiates chapeau + statutory definition of "Isomer"

Source

https://ksrevisor.gov/statutes/chapters/ch65/065_041_0005.html

Retrieved

2026-07-06

Fingerprint

f8abde9482f83e9b

K.S.A. 65-4105(b) (Schedule I - opiates), chapeau:
"(b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:"
Relevant listed entries (added by HB 2365 and SB 430, effective July 1, 2026):
"(32) 7-hydroxymitragynine (7-OH)"
“(42) Mitragynine”

K.S.A. 65-4101(y) (Kansas Uniform Controlled Substances Act - Definitions):
"(y) \"Isomer\" means all enantiomers and diastereomers."